Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)

Sanara MedTech's Current Deferred Revenue history spans 2 years, with the latest figure at $10474.0 for Q4 2018.

For Q4 2018, Current Deferred Revenue fell 24.76% year-over-year to $10474.0; the TTM value through Dec 2018 reached $10474.0, down 24.76%, while the annual FY2018 figure was $10474.0, 24.76% down from the prior year.
Current Deferred Revenue reached $10474.0 in Q4 2018 per SMTI's latest filing, down from $12141.0 in the prior quarter.
In the past five years, Current Deferred Revenue ranged from a high of $13920.0 in Q4 2017 to a low of $10474.0 in Q4 2018.